Morgan Stanley Gilead Sciences, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 17,248,558 shares of GILD stock, worth $1.62 Billion. This represents 0.11% of its overall portfolio holdings.

Number of Shares

17,248,558

Previous 19,337,304 10.8%

Holding current value

$1.62 Billion

Previous $1.33 Billion 8.97%

% of portfolio

0.11%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $139 Million - $175 Million	-2,088,746 Reduced 10.8%	17,248,558 $1.45 Billion
Q2 2024 Oct 17, 2024	BUY	$63.15 - $72.88 $83.6 Million - $96.5 Million	1,323,720 Added 7.35%	19,337,304 $1.33 Billion
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $83.6 Million - $96.5 Million	1,323,720 Added 7.35%	19,337,304 $1.33 Billion
Q1 2024 Oct 17, 2024	SELL	$71.58 - $87.29 $94.8 Million - $116 Million	-1,323,720 Reduced 6.85%	18,013,584 $1.32 Billion
Q1 2024 Aug 16, 2024	BUY	$71.58 - $87.29 $15.2 Million - $18.5 Million	211,866 Added 1.19%	18,013,584 $1.32 Billion
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $15.2 Million - $18.5 Million	211,866 Added 1.19%	18,013,584 $1.32 Billion
Q4 2023 Aug 16, 2024	SELL	$73.27 - $83.09 $113 Million - $128 Million	-1,535,586 Reduced 7.94%	17,801,718 $1.44 Billion
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $65.4 Million - $74.1 Million	892,099 Added 5.28%	17,801,718 $1.44 Billion
Q3 2023 Nov 15, 2023	BUY	$73.94 - $80.67 $11.7 Million - $12.8 Million	158,794 Added 0.95%	16,909,619 $1.27 Billion
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $48.9 Million - $55.8 Million	643,281 Added 3.99%	16,750,825 $1.29 Billion
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $84.2 Million - $96 Million	-1,089,406 Reduced 6.33%	16,107,544 $1.34 Billion
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $111 Million - $159 Million	1,780,489 Added 11.55%	17,196,950 $1.48 Billion
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $144 Million - $164 Million	-2,410,165 Reduced 13.52%	15,416,461 $951 Million
Q2 2022 Oct 27, 2022	BUY	$57.72 - $65.01 $249 Million - $281 Million	4,321,514 Added 32.0%	17,826,626 $1.1 Billion
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $249 Million - $281 Million	4,321,514 Added 32.0%	17,826,626 $1.1 Billion
Q1 2022 Oct 27, 2022	SELL	$57.92 - $72.58 $250 Million - $314 Million	-4,321,514 Reduced 24.24%	13,505,112 $803 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $123 Million - $154 Million	-2,124,284 Reduced 13.59%	13,505,112 $803 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $14.9 Million - $16.9 Million	229,768 Added 1.49%	15,629,396 $1.13 Billion
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $1.04 Billion - $1.12 Billion	15,399,628 New	15,399,628 $1.08 Billion

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account